Christopher E. Mason, PhD

Co-Founder
Biotia Inc.

Disclosure(s): Biotia Inc.: Advisor/Consultant, Board Member, Ownership Interest

Poster(s):

• 322 - Clinical-Grade Metagenomics in Urinary Tract Infections: Improving Performance of Next-Generation Sequencing Assays Using Internal Controls and Machine Learning
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET